Senti Biosciences (SNTI) Return on Sales (2021 - 2024)
Senti Biosciences (SNTI) has 4 years of Return on Sales data on record, last reported at 0.08% in Q3 2024.
- For Q3 2024, Return on Sales fell 6409.0% year-over-year to 0.08%; the TTM value through Sep 2024 reached 0.08%, up 147.0%, while the annual FY2023 figure was 6.24%, 824.0% up from the prior year.
- Return on Sales reached 0.08% in Q3 2024 per SNTI's latest filing, down from 4332.8% in the prior quarter.
- Across five years, Return on Sales topped out at 4332.8% in Q2 2024 and bottomed at 265.53% in Q4 2022.
- Average Return on Sales over 4 years is 293.08%, with a median of 1.48% recorded in 2021.
- Peak YoY movement for Return on Sales: plummeted -26172bps in 2022, then soared 433754bps in 2024.
- A 4-year view of Return on Sales shows it stood at 3.81% in 2021, then crashed by -6874bps to 265.53% in 2022, then skyrocketed by 100bps to 0.08% in 2023, then changed by 0bps to 0.08% in 2024.
- Per Business Quant database, its latest 3 readings for Return on Sales were 0.08% in Q3 2024, 4332.8% in Q2 2024, and 18.28% in Q1 2024.